313 related articles for article (PubMed ID: 19826393)
1. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
Kitnarong N; Chindasub P; Metheetrairut A
Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
[TBL] [Abstract][Full Text] [Related]
5. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
9. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
[TBL] [Abstract][Full Text] [Related]
11. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
[TBL] [Abstract][Full Text] [Related]
12. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
Wolf A; von Jagow B; Ulbig M; Haritoglou C
Ophthalmologica; 2011; 226(2):51-6. PubMed ID: 21546781
[TBL] [Abstract][Full Text] [Related]
13. Topical bevacizumab for neovascular glaucoma: a pilot study.
Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
[TBL] [Abstract][Full Text] [Related]
14. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
16. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients.
Cornish KS; Ramamurthi S; Saidkasimova S; Ramaesh K
Eye (Lond); 2009 Apr; 23(4):979-81. PubMed ID: 18451875
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
